Evaluation of gilteritinib in combination with chemotherapy in preclinical models of FLT3-ITD(+) acute myeloid leukemia

Activating internal tandem duplication (ITD) and tyrosine kinase domain (TKD) point mutations in Fms-like tyrosine kinase 3 (FLT3) occur in approximately 30% of patients with acute myeloid leukemia (AML), and confer a poor prognosis with standard cytarabine/anthracycline or azacitidine-based chemoth...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Ueno, Yoko, Mori, Masamichi, Kamiyama, Yoshiteru, Saito, Rika, Kaneko, Naoki, Isshiki, Eriko, Kuromitsu, Sadao, Takeuchi, Masahiro
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2019
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6493465/
https://ncbi.nlm.nih.gov/pubmed/31069015
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.26811
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados